6th Gene Therapy Analytical Development and CMC Summit
Evvnt Promotion / evvnt
Archive
30.10.2024 - 01.11.2024 The Westin Copley Place, 10 Huntington Ave, 02116 Boston, Massachusetts, USA
Time: 9:00 AM - 5:00 PM
Conference themes
Twelve gene therapies have been approved by the FDA to date to treat a variety of diseases, including the first ever gene edited therapeutic. The CMC package required to effectively demonstrate safety and efficacy of increasingly complex gene therapy products to regulators needs to keep pace.
Twelve gene therapies have been approved by the FDA to date to treat a variety of diseases, including the first ever gene edited therapeutic. The CMC package required to effectively demonstrate safety and efficacy of increasingly complex gene therapy products to regulators needs to keep pace.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Notes
URL:
Brochure: https://go.evvnt.com/2481285-3?pid=4832
Speakers: Luke Arbogast Director, R and D Eli Lilly, Surya Addepalli Scientist, Gene Therapy Research BioMarin, Steven Berkowitz Consultant Pacira , and more
URL:
Brochure: https://go.evvnt.com/2481285-3?pid=4832
Speakers: Luke Arbogast Director, R and D Eli Lilly, Surya Addepalli Scientist, Gene Therapy Research BioMarin, Steven Berkowitz Consultant Pacira , and more
Enquiries and Registration:
https://go.evvnt.com/2481285-2?pid=4832
Ms. Karina Bikerniece
General Medicine
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
